DO
MRNA icon

denkapparat Operations’s Moderna MRNA Stock Holding History

denkapparat Operations’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$246K Buy
+4,848
New +$226K 0.1% 297

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

denkapparat Operations's MRNA Position: Q1 2026 in Review

denkapparat Operations opened a new position in Moderna (MRNA) in Q1 2026: 4,848 shares worth $246K. The stake represents 0.1% of the portfolio and ranks #297 among its holdings.

722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • denkapparat Operations held 4,848 shares of Moderna worth $246K as of Q1 2026.
  • Moderna was a new denkapparat Operations position in Q1 2026.
  • Moderna made up 0.1% of denkapparat Operations's portfolio in Q1 2026, its #297 holding.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on denkapparat Operations's 13F filing for Q1 2026, filed 11 May 2026.